
Clinical and research platforms for invasive and non‑invasive neural interfaces, closed‑loop stimulation, and cognitive therapies under strict governance.
Clinical studies proceed only with appropriate oversight and approvals, with patient safety monitoring and data governance.
Design controls, risk management, and biocompatibility testing with documented validation.
Invasive electrode arrays, non‑invasive EEG/MEG, and peripheral interfaces.
Yes. Adaptive protocols driven by patient‑specific models and outcomes.
Explore partnership opportunities or learn more about our Neurotechnologies capabilities.